Correction of glycogen storage disease type III with rapamycin in a canine model.
about
Preclinical Development of New Therapy for Glycogen Storage Diseases.Large animal models and new therapies for glycogen storage disease.Natural Progression of Canine Glycogen Storage Disease Type IIIa.Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts.ORM Promotes Skeletal Muscle Glycogen Accumulation via CCR5-Activated AMPK Pathway in MiceA Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV.Myocardial glycogen dynamics: new perspectives on disease mechanisms.A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease.The dog aging project: translational geroscience in companion animals.High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction.Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs.Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs.
P2860
Q35677604-92ED5498-173D-4CE4-84D8-6B5C4553DCA1Q35886078-C9F6661C-7030-4950-AF04-858A4DD2830FQ36575670-7C6E0709-BF55-4F1B-B0DD-493022800D54Q36681450-3F92A763-F793-4E9B-86AA-5E9BEC551943Q37250309-2D17AD48-5EF0-4A4F-B9FE-725E36EB8761Q37415869-2ABBF32E-7A6D-461A-94B3-1B2785D3BD74Q38353514-20DA56E4-C25B-43FD-A4E5-9DE07D7BEC95Q38650286-1370DAB4-9BDA-491B-B9DA-D4043DBC6127Q38824857-AC729EF6-D504-4812-B480-C26069A7DD1CQ41093396-57E886A2-2967-4649-9B57-EAB25F0873D1Q42251874-E4670173-A14F-4C13-A30C-762F670D4FDFQ48507292-F6422D2A-0940-4449-9BD5-41F335527602Q55174539-434EF0F8-A9A0-4323-A967-260AE4910665
P2860
Correction of glycogen storage disease type III with rapamycin in a canine model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Correction of glycogen storage disease type III with rapamycin in a canine model.
@en
Correction of glycogen storage disease type III with rapamycin in a canine model.
@nl
type
label
Correction of glycogen storage disease type III with rapamycin in a canine model.
@en
Correction of glycogen storage disease type III with rapamycin in a canine model.
@nl
prefLabel
Correction of glycogen storage disease type III with rapamycin in a canine model.
@en
Correction of glycogen storage disease type III with rapamycin in a canine model.
@nl
P2093
P2860
P1476
Correction of glycogen storage disease type III with rapamycin in a canine model.
@en
P2093
Baodong Sun
Beth L Thurberg
John C Fyfe
Priya S Kishnani
P2860
P2888
P304
P356
10.1007/S00109-014-1127-4
P577
2014-02-08T00:00:00Z